No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 10, 2008, Pages 1742-1749

  Sovershaev, M A ^a   Lind, K F ^b   Devold, H ^b   Jorgensen T O ^b   Hansen, J B ^b   Osterud B ^b   Egorina, Elena M ^b,c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Eosinophils; Immunologic purification; Monocytes; Tissue factor expression

Indexed keywords

CD14 ANTIGEN; MESSENGER RNA; PROCOAGULANT; THROMBOPLASTIN;

ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL LYSATE; CELL STIMULATION; CELL SURFACE; CONTAMINATION; CONTROLLED STUDY; EOSINOPHIL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOLOGICAL PROCEDURES; MONOCYTE; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL SEPARATION; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; MONOCYTES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOPLASTIN;

EID: 52449131380     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03105.x     Document Type: Article

References (38)

1. Broze GJ Jr. Binding of human factor VII and VIIa to monocytes. J Clin Invest 1982; 70: 526-35.
2. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-4.
3. Mackman N, Morrissey JH, Fowler B, Edgington TS. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 1989; 28: 1755-62.
4. Nemerson Y. The reaction between bovine brain tissue factor and factors VII and X. Biochemistry 1966; 5: 601-8.
5. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
6. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
7. Osterud B. Tissue factor in neutrophils: No. J Thromb Haemost 2004; 2: 218-20.
8. Nakamura S, Imamura T, Okamoto K. Tissue factor in neutrophils: Yes. J Thromb Haemost 2004; 2: 214-17.
9. Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost 2006; 32: 11-23.
10. Maugeri N, Brambilla M, Camera M, Carbone A, Tremoli E, Donati MB, de Gaetano G, Cerletti C. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost 2006; 4: 1323-30.
11. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 2007; 109: 995-1002.
12. Mechiche H, Cornillet-Lefebvre P, Nguyen P. A subpopulation of human B lymphocytes can express a functional tissue factor in response to phorbol myristate acetate. Thromb Haemost 2005; 94: 146-54.
13. Mechiche H, Nguyen P. IL-4 modulates tissue factor expression by human B lymphocytes in response to phorbol myristate acetate. Thromb Haemost 2007; 97: 158-9.
14. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, Rondina MT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 2006; 203: 2433-40.
15. Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 2007; 14: 55-61.
16. Rak J, Yu JL, Luyendyk J, Mackman N. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res 2006; 66: 10643-6.
17. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24: 1015-22.
18. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 1996; 3: 379-84.
19. Mann KG. Thrombin: Can't live without it; probably die from it. Chest 2003; 124: 1S-3S.
20. Egorina EM, Sovershaev MA, Olsen JO, Osterud B. Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood 2008; 111: 1208-16.
21. Sovershaev MA, Egorina EM, Gruber FX, Olsen JO, Osterud B. High tissue factor-expressing human monocytes carry low surface CD36: Application to intersubject variability. J Thromb Haemost 2007; 5: 2453-60.
22. Egorina EM, Sovershaev MA, Osterud B. In-cell Western assay: A new approach to visualize tissue factor in human monocytes. J Thromb Haemost 2006; 4: 614-20.
23. Egorina EM, Sovershaev MA, Kondratiev TV, Olsen JO, Tveita T, Osterud B. Induction of monocytic tissue factor expression after rewarming from hypothermia in vivo is counteracted by heat shock in c-Jun-dependent manner. Arterioscler Thromb Vasc Biol 2006; 26: 2401-6.
24. Osterud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes. J Leukoc Biol 1992; 51: 462-5.
25. Egorina EM, Sovershaev MA, Bjorkoy G, Gruber FX, Olsen JO, Parhami-Seren B, Mann KG, Østerud B. Intracellular and surface distribution of monocyte tissue factor: Application to intersubject variability. Arterioscler Thromb Vasc Biol 2005; 25: 1493-8.
26. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 1999; 274: 25933-44.
27. Arlandson M, Decker T, Roongta VA, Bonilla L, Mayo KH, MacPherson JC, Hazen SL, Slungaard A. Eosinophil peroxidase oxidation of thiocyanate. Characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system. J Biol Chem 2001; 276: 215-24.
28. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 651-63.
29. Wang JG, Mahmud SA, Thompson JA, Geng JG, Key NS, Slungaard A. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: A potential mechanism for thrombosis in eosinophilic inflammatory states. Blood 2006; 107: 558-65.
30. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759-79.
31. Brito-Babapulle F. The eosinophilias, including the idiopathic hypereosinophilic syndrome. Br J Haematol 2003; 121: 203-23.
32. Fitzpatrick JE, Johnson C, Simon P, Owenby J. Cutaneous microthrombi: A histologic clue to the diagnosis of hypereosinophilic syndrome. Am J Dermatopathol 1987; 9: 419-22.
33. Kojima K, Sasaki T. Veno-occlusive disease in hypereosinophilic syndrome. Intern Med 1995; 34: 1194-7.
34. Schulman H, Hertzog L, Zirkin H, Hertzanu Y. Cerebral sinovenous thrombosis in the idiopathic hypereosinophilic syndrome in childhood. Pediatr Radiol 1999; 29: 595-7.
35. Valente O, Scarpinella-Bueno MA. Deep venous thrombosis in hypereosinophilic syndrome. Am Fam Physician 1994; 50: 921-2.
36. Osterud B, Rao LV, Olsen JO. Induction of tissue factor expression in whole blood: Lack of evidence for the presence of tissue factor expression in granulocytes. Thromb Haemost 2000; 83: 861-7.
37. Simon HU. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev 2003; 193: 101-10.
38. Brand K, Fowler BJ, Edgington TS, Mackman N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol 1991; 11: 4732-8.